Semaglutide 10mg - Third-Party Test Results
Manufacturer: LeoLab™
Sample: Semaglutide 10mg
Date: 04 DEC 2024
LeoLab™ is proud to maintain its reputation for producing high-quality peptides, verified through rigorous third-party testing. A recent independent analysis conducted by Janoshik Analytical has confirmed the exceptional quality of LeoLab’s Semaglutide 10mg. The analysis was carried out under task number 53571, with a sample from batch G59843, tested on 04 December 2024. These tests are critical to ensuring the safety, efficacy, and reliability of our products.
The results from this latest test highlight the superior quality of LeoLab’s Semaglutide 10mg. The analysis revealed an impressive purity level of 99.776%, far exceeding standard expectations. Additionally, the test confirmed a mass measurement of 11.27 mg, demonstrating consistency and accuracy in production. These findings underscore LeoLab’s commitment to providing research-grade peptides of unparalleled quality.